Innoviz CFO receives new options and RSU grant
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Innoviz Technologies Chief Financial Officer Eldar Mordechay Cegla reported equity compensation grants dated August 4, 2026. He received 78,416 share options with a $0.42 exercise price expiring on August 4, 2033 and 73,184 RSUs, both vesting one-fourth on August 4, 2027 with the remainder vesting quarterly through 2030, subject to continued service. After these awards, he is reported as holding 537,237 ordinary shares, including 234,628 shares issuable upon vesting of RSUs.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Share Option F4 | 78,416 | $0.00 | $0.00 |
| Grant/Award | Ordinary Shares F1, F2, F3 | 73,184 | $0.00 | $0.00 |
Footnotes (4)
- F1. Represents 73,184 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.
- F2. Includes 234,628 ordinary shares issuable upon vesting of RSUs; of which (a) 2,607 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 11,104 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 13,109 RSUs granted February 27, 2024, with 2,616 vesting quarterly through 2027 and 10,493 vesting quarterly through 2028; (d) 25,524 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 15,092 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 41,016 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 52,992 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 73,184 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030.
- F3. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.
- F4. Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
Key Figures
Key Terms
exercise price financial
vesting financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Innoviz (INVZ) grant to its CFO on August 4, 2026?
What is the size and vesting structure of the 73,184 RSUs granted by Innoviz (INVZ)?
Are the Innoviz (INVZ) equity awards to the CFO subject to continued service conditions?
AI-generated analysis. How Rhea-AI works. Not financial advice.